Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C19H23N7O6 |
| Molecular Weight | 445.4292 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
InChI
InChIKey=MSTNYGQPCMXVAQ-KIYNQFGBSA-N
InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1
| Molecular Formula | C19H23N7O6 |
| Molecular Weight | 445.4292 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Tetrahydrofolic acid is a folic acid derivative. It is produced from dihydrofolic acid by dihydrofolate reductase. It is converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. It is a coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids. It acts as a donor of a group with one carbon atom. It gets this carbon atom by sequestering formaldehyde produced in other processes. Tetrahydrofolate is the main active metabolite of dietary folate. It is vital as a coenzyme in reactions involving transfers of single carbon groups. Tetrahydrofolate has a role in nucleic and amino acid synthesis. As nucleic and amino acid synthesis is affected by a deficiency of tetrahydrofolate, actively dividing and growing cells tend to be the first affected. Tetrahydrofolate is used to treat topical sprue and megaloblastic and macrocytic anemias, hematologic complications resulting from a deficiency in folic acid. Tetrahydrofolic acid is used for nutritional supplementation, also for treating dietary shortage or imbalance.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Tetrahydrofolate recognition by the mitochondrial folate transporter. | 2011-09-09 |
|
| Enzymatic properties of ALDH1L2, a mitochondrial 10-formyltetrahydrofolate dehydrogenase. | 2011-05-30 |
|
| A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. | 2007-04 |
|
| Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation. | 2006-09-01 |
|
| Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53-dependent manner. | 2006-06 |
|
| Sodium-dependent methotrexate carrier-1 is expressed in rat kidney: cloning and functional characterization. | 2004-03 |
|
| Biosynthesis of tetrahydrofolate. Stereochemistry of dihydroneopterin aldolase. | 2002-08-09 |
|
| Molecular cloning of the human placental folate transporter. | 1995-01-17 |
|
| Thymidylate synthetase activity in the Novikoff hepatoma. | 1976-12 |
|
| The toxicity of tetrahydrohomofolic acid in normal and malaria-infected monkeys. | 1968-02 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02639650
Tetrahydrofolic acid is used as a component of methotrexate chemotherapy treatment of Gestational Trophoblastic Neoplasms: methotrexate 100mg/m2, 200mg/m2, ivgtt, tetrahydrofolic acid (FA) 15mg q12h*4(24h after methotrexate injection),started at the first day of cycle, two weeks a cycle.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6129582
Tetrahydrofolic acid at 100 uM concentration didn`t significantly inhibit the specific binding of [3H]-KA to striatal membranes.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:56:16 GMT 2025
by
admin
on
Mon Mar 31 21:56:16 GMT 2025
|
| Record UNII |
43ZWB253H4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
135-16-0
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
100000141677
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
DB00116
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
205-181-1
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
SUB96099
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
135444742
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
15635
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
20506
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
Tetrahydrofolic acid
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
DTXSID70897520
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY | |||
|
43ZWB253H4
Created by
admin on Mon Mar 31 21:56:16 GMT 2025 , Edited by admin on Mon Mar 31 21:56:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |